Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Kartika Widjaja"'
Autor:
Steven H. Olson, Sabeen A. Kazmi, Smita S. Patel, Kartika Widjaja, Daniel A. Mordes, Amanda L. Woerman, Atsushi Aoyagi, Stanley B. Prusiner, Abby Oehler
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America. 115(2)
Significance In Parkinson’s disease (PD) and multiple system atrophy (MSA), the accumulation and spread of α-synuclein prions leads to the progressive degeneration seen in patients. These diseases are thought to arise from unique conformations of
Autor:
Joel R. Gever, Matthew P. Jacobson, Kartika Widjaja, Satish Rao, Adam R. Renslo, Sina Ghaemmaghami, Stanley B. Prusiner, John J. Irwin, B. Michael Silber, Zhe Li, Alejandra Gallardo-Godoy
Publikováno v:
Bioorganic & Medicinal Chemistry. 21:7999-8012
During prion diseases, a normally benign, host protein, denoted PrPC, undergoes alternative folding into the aberrant isoform, PrPSc. We used ELISA assays to identify and confirm hits in order to develop leads that reduce PrPSc in prion-infected divi
Autor:
William W. Seeley, Smita S. Patel, Atsushi Aoyagi, Amanda L. Woerman, Thomas C. Südhof, Joel C. Watts, Zuzana Krejciova, Kurt Giles, Daniel A. Mordes, Jan Stöhr, David W. Sanders, Steve M. Gentleman, Ryan Rampersaud, Kartika Widjaja, Takao Ohyama, Abby Oehler, Lefkos T. Middleton, Stanley B. Prusiner, Marc I. Diamond
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, vol 112, iss 35
Woerman, AL; Stöhr, J; Aoyagi, A; Rampersaud, R; Krejciova, Z; Watts, JC; et al.(2015). Propagation of prions causing synucleinopathies in cultured cells. Proceedings of the National Academy of Sciences of the United States of America, 112(35), E4949-E4958. doi: 10.1073/pnas.1513426112. UCSF: Retrieved from: http://www.escholarship.org/uc/item/4mg1p0r6
Woerman, AL; Stöhr, J; Aoyagi, A; Rampersaud, R; Krejciova, Z; Watts, JC; et al.(2015). Propagation of prions causing synucleinopathies in cultured cells. Proceedings of the National Academy of Sciences of the United States of America, 112(35), E4949-E4958. doi: 10.1073/pnas.1513426112. UCSF: Retrieved from: http://www.escholarship.org/uc/item/4mg1p0r6
© 2015, National Academy of Sciences. All rights reserved. Increasingly, evidence argues that many neurodegenerative diseases, including progressive supranuclear palsy (PSP), are caused by prions, which are alternatively folded proteins undergoing s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b51bd859069006b22593b3cf83b15aae
https://escholarship.org/uc/item/4mg1p0r6
https://escholarship.org/uc/item/4mg1p0r6
Autor:
Mike Pyne, Paul B. Robbins, Robert R. Becklin, Kartika Widjaja, Shuping Lai, Sam Thompson, Lawrence Weir, J. Jay Boniface, Yew-Seng J. Ho, John M. Peltier, Moritz von Rechenberg, Cindy Lou Chepanoske, Peter J. Sheffield, Srdjan Askovic, Yuejun Zhen, Justin Savage, Vladimir Kery, Bonnie Richardson, Nafei Xu, Tahmina Mujtaba
Publikováno v:
International Journal of Mass Spectrometry. 238:119-130
Proteomics-based technologies have the potential to accelerate the development of drugs, but such technologies must be well integrated in order to have a positive impact. We describe, herein, a multi-step process for the discovery of protein–protei
Autor:
David R. Conklin, J. Jay Boniface, Justin Savage, Thomas Zarembinski, Xinghua Long, Kartika Widjaja, Vladimir Kery, Moritz von Rechenberg, Yew-Seng J. Ho, B. Kelly Blake
Publikováno v:
Analytical Biochemistry. 317:255-258
High-throughput purification of affinity-tagged fusion proteins is currently one of the fastest developing areas of molecular proteomics. A prerequisite for success in protein purification is sufficient soluble protein expression of the target protei
Autor:
Zhe Li, Casper Wong, Joel R. Gever, Kurt Giles, Kartika Widjaja, Satish Rao, Matthew P. Jacobson, Yevgeniy Freyman, Adam R. Renslo, Manuel Elepano, Stanley B. Prusiner, John J. Irwin, B. Michael Silber
Publikováno v:
Bioorganic & medicinal chemistry, vol 22, iss 6
Silber, BM; Gever, JR; Rao, S; Li, Z; Renslo, AR; Widjaja, K; et al.(2014). Novel compounds lowering the cellular isoform of the human prion protein in cultured human cells. Bioorganic and Medicinal Chemistry, 22(6), 1960-1972. doi: 10.1016/j.bmc.2014.01.001. UCSF: Retrieved from: http://www.escholarship.org/uc/item/5r2396fv
Silber, BM; Gever, JR; Rao, S; Li, Z; Renslo, AR; Widjaja, K; et al.(2014). Novel compounds lowering the cellular isoform of the human prion protein in cultured human cells. Bioorganic and Medicinal Chemistry, 22(6), 1960-1972. doi: 10.1016/j.bmc.2014.01.001. UCSF: Retrieved from: http://www.escholarship.org/uc/item/5r2396fv
Purpose: Previous studies showed that lowering PrPC concomitantly reduced PrPSc in the brains of mice inoculated with prions. We aimed to develop assays that measure PrPC on the surface of human T98G glioblastoma and IMR32 neuroblastoma cells. Using
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c464fd6f59b5218affb72b4a8c4a6d8
https://escholarship.org/uc/item/5r2396fv
https://escholarship.org/uc/item/5r2396fv
Publikováno v:
Li, Z; Rao, S; Gever, JR; Widjaja, K; Prusiner, SB; & Michael Silber, B. (2013). Towards optimization of arylamides as novel, potent, and brain-penetrant antiprion lead compounds. ACS Medicinal Chemistry Letters, 4(7), 647-650. doi: 10.1021/ml300454k. UCSF: Retrieved from: http://www.escholarship.org/uc/item/85p0892q
The prion diseases caused by PrPSc, an alternatively folded form of the cellular prion protein (PrPC), are rapidly progressive, fatal, and untreatable neurodegenerative disorders. We employed HTS ELISA assays to identify compounds that lower the leve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79c9507677646bb264dc6cc7f70dcf83
http://www.escholarship.org/uc/item/85p0892q
http://www.escholarship.org/uc/item/85p0892q
Autor:
Satish Rao, Joel R. Gever, Zhe Li, Clifford Bryant, Stanley B. Prusiner, Elena Dolghih, Alejandra Gallardo-Godoy, Manuel Elepano, Adam R. Renslo, Matthew P. Jacobson, Kartika Widjaja, B. Michael Silber
Publikováno v:
ChemMedChem, vol 8, iss 5
Li, Z; Silber, BM; Rao, S; Gever, JR; Bryant, C; Gallardo-Godoy, A; et al.(2013). 2-Aminothiazoles with Improved Pharmacotherapeutic Properties for Treatment of Prion Disease. ChemMedChem, 8(5), 847-857. doi: 10.1002/cmdc.201300007. UCSF: Retrieved from: http://www.escholarship.org/uc/item/33t9f431
Li, Z; Silber, BM; Rao, S; Gever, JR; Bryant, C; Gallardo-Godoy, A; et al.(2013). 2-Aminothiazoles with Improved Pharmacotherapeutic Properties for Treatment of Prion Disease. ChemMedChem, 8(5), 847-857. doi: 10.1002/cmdc.201300007. UCSF: Retrieved from: http://www.escholarship.org/uc/item/33t9f431
Recently, we described the aminothiazole lead (4-biphenyl-4-ylthiazol-2-yl)-(6-methylpyridin-2-yl)-amine (1), which exhibits many desirable properties, including excellent stability in liver microsomes, oral bioavailability of ∼40%, and high exposu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c0f661215216cd16384f92e82bc0d7f
https://escholarship.org/uc/item/33t9f431
https://escholarship.org/uc/item/33t9f431
Publikováno v:
Li, Z; Gever, JR; Rao, S; Widjaja, K; Prusiner, SB; & Silber, BM. (2013). Discovery and preliminary structure-activity relationship of arylpiperazines as novel, brain-penetrant antiprion compounds. ACS Medicinal Chemistry Letters, 4(4), 397-401. doi: 10.1021/ml300472n. UCSF: Retrieved from: http://www.escholarship.org/uc/item/6zc5651q
Creutzfeldt-Jakob disease and kuru in humans, BSE in cattle, and scrapie in sheep are fatal neurodegenerative disorders. Such illnesses are caused by the conversion and accumulation of a misfolded pathogenic isoform (termed PrPSc) of a normally benig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3bb45bdc4c4156a02881f12edf109083
https://europepmc.org/articles/PMC3704178/
https://europepmc.org/articles/PMC3704178/
Autor:
Tina Tran, Siddhartha Mitra, Jason Miller, Earl E. Rutenber, Karl H. Weisgraber, Danny M. Hatters, Dean Taylor, Kartika Widjaja, Kenneth Cheung, Yvonne M. Newhouse, Clare Peters-Libeu, Luis A. Mosquera, Steven Finkbeiner, Preethi Krishnan, Elizabeth Brooks, Montserrat Arrasate
Publikováno v:
Journal of molecular biology, vol 421, iss 4-5
Peters-Libeu, C; Miller, J; Rutenber, E; Newhouse, Y; Krishnan, P; Cheung, K; et al.(2012). Disease-associated polyglutamine stretches in monomeric huntingtin adopt a compact structure. Journal of Molecular Biology, 421(4-5), 587-600. doi: 10.1016/j.jmb.2012.01.034. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/6tr8t4jw
Peters-Libeu, C; Miller, J; Rutenber, E; Newhouse, Y; Krishnan, P; Cheung, K; et al.(2012). Disease-associated polyglutamine stretches in monomeric huntingtin adopt a compact structure. Journal of Molecular Biology, 421(4-5), 587-600. doi: 10.1016/j.jmb.2012.01.034. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/6tr8t4jw
Abnormal polyglutamine (polyQ) tracts are the only common feature in nine proteins that each cause a dominant neurodegenerative disorder. In Huntington's disease, tracts longer than 36 glutamines in the protein huntingtin (htt) cause degeneration. In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ccdc082ba23917bc657b0ed36d874c0
https://europepmc.org/articles/PMC3358578/
https://europepmc.org/articles/PMC3358578/